Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2020

Apr 22, 2020

33899_dirs_2020-04-22_4f357f2b-0aac-4aac-bd17-344d1c01abec.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2020-02-19

Reporting Person: Chard Daniel R (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-19 Common Stock A 11359 Acquired 140329 Direct
2020-02-20 Common Stock F 1.348 $101.45 Disposed 138981 Direct

Footnotes

F1: The amount of securities acquired on February 19, 2020 was erroneously reported as 10,172 in the original Form 4 filed on February 21, 2020. This error impacted total beneficial ownership in this form. This amendment is being filed to include 1,187 erroneously omitted from the reporting person's Form 4 as originally filed.